{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:57:34Z","timestamp":1791089854921,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2023-02497"],"award-info":[{"award-number":["2023-02497"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2022-00763"],"award-info":[{"award-number":["2022-00763"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stiftelsen Konung Gustaf den V: e 80-\u00e5rs fond","award":["FAI2023-0958"],"award-info":[{"award-number":["FAI2023-0958"]}]},{"name":"Stiftelsen Konung Gustaf den V: e 80-\u00e5rs fond","award":["FAI-2023\u20130956"],"award-info":[{"award-number":["FAI-2023\u20130956"]}]},{"name":"Stiftelsen Konung Gustaf den V: e 80-\u00e5rs fond","award":["FAI2022-0901"],"award-info":[{"award-number":["FAI2022-0901"]}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","award":["R1025817"],"award-info":[{"award-number":["R1025817"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","award":["R-1012541"],"award-info":[{"award-number":["R-1012541"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","award":["R995666"],"award-info":[{"award-number":["R995666"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region Stockholm Kliniska Post-doktorer","award":["FoUI-989648"],"award-info":[{"award-number":["FoUI-989648"]}]},{"name":"KI Research Foundation","award":["CR2025-0032"],"award-info":[{"award-number":["CR2025-0032"]}]},{"name":"KI Research Foundation","award":["2024-02579"],"award-info":[{"award-number":["2024-02579"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>In SLE, expanded B cell subtypes like double-negative 2 (DN2) may harbour autoreactivity, which may be linked to impaired checkpoint regulation. We investigated checkpoint molecule CD72 on B cells, its clinical associations, and dynamic changes upon rituximab (RTX) treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty SLE patients (26 with active disease) were studied. Seven received RTX treatment with sampling at baseline, 3\u2009months and 6\u2009months. B cell phenotypes were analysed using spectral flow cytometry, and clinical associations were evaluated. B cell receptor (BCR) signalling was studied through downstream phosphorylation in vitro.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with active SLE showed increased frequencies of CD72-negative B cells in switched memory (SWM), activated na\u00efve (aNAV), DN2 and plasmablast (PB) subsets compared with healthy controls (HCs). CD72-negative DN2 cells (CD27-IgD-CD21-CD11c+) were elevated in LN patients. These cells expressed higher CD95 and lower CD20 compared with HCs and canonical SLE DN2. Upon BCR stimulation, lupus CD72-negative SWM and DN2 B cells displayed increased pSYK phosphorylation compared with their CD72-positive counterparts and the overall cell population. CD72-negative DN2 frequencies associated positively with SLEDAI-2K and inversely with C3 levels and were increased in anti-dsDNA-positive patients. After RTX treatment, the remaining DN2 cells were primarily CD72-negative at 3\u2009months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The DN2 B cell subset have been associated with autoimmunity. We showed that DN2 B cells in SLE have reduced CD72 expression, which is associated with anti-dsDNA positivity, complement consumption, and enhanced BCR downstream signalling. The relative resistance of CD72-negative B cells to RTX indicates that an impaired checkpoint programme in lupus B cells may potentially contribute to disease relapse. These findings require validation in larger cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag097","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:19:35Z","timestamp":1771244375000},"source":"Crossref","is-referenced-by-count":3,"title":["CD72 downregulation on DN2 B cells is associated with disease activity and resistance to rituximab in systemic lupus erythematosus"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-076X","authenticated-orcid":false,"given":"Kittikorn","family":"Wangriatisak","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sechi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilija","family":"Oke","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Centre for Rheumatology, Academic Specialist Centre , Stockholm Region,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Chemin","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-5537","authenticated-orcid":false,"given":"Caroline","family":"Gr\u00f6nwall","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Medicine Unit Dermatology, Gastroenterology, Rheumatology; Section of Rheumatology, Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9251-8082","authenticated-orcid":false,"given":"Vivianne","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Faustini","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Medicine Unit Dermatology, Gastroenterology, Rheumatology; Section of Rheumatology, Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"2026030916370699000_keag097-B1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imr.12815","article-title":"Autoreactive B cells in SLE, villains or innocent bystanders?","volume":"292","author":"Hamilton","year":"2019","journal-title":"Immunol Rev"},{"key":"2026030916370699000_keag097-B2","doi-asserted-by":"crossref","first-page":"103851","DOI":"10.1016\/j.autrev.2025.103851","article-title":"Autoreactive B cells in autoimmune diseases: mechanisms, functions and clinical implications","volume":"24","author":"Collet","year":"2025","journal-title":"Autoimmun Rev"},{"key":"2026030916370699000_keag097-B3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"},{"key":"2026030916370699000_keag097-B4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12927","article-title":"Antibody repertoire analysis in polygenic autoimmune diseases","volume":"155","author":"Bashford-Rogers","year":"2018","journal-title":"Immunology"},{"key":"2026030916370699000_keag097-B5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nri3190","article-title":"Integration of B cell responses through Toll-like receptors and antigen receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2026030916370699000_keag097-B6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4110\/in.2019.19.e1","article-title":"CD72 is a negative regulator of B cell responses to nuclear lupus self-antigens and development of systemic lupus erythematosus","volume":"19","author":"Tsubata","year":"2019","journal-title":"Immune Netw"},{"key":"2026030916370699000_keag097-B7","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1084\/jem.20160560","article-title":"CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm\/RNP","volume":"213","author":"Akatsu","year":"2016","journal-title":"J Exp Med"},{"key":"2026030916370699000_keag097-B8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"2026030916370699000_keag097-B9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"2026030916370699000_keag097-B10","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2026030916370699000_keag097-B11","doi-asserted-by":"crossref","first-page":"e13427","DOI":"10.1111\/sji.13427","article-title":"Association between peripheral activated na\u00efve and double negative 2 B-cell subsets and clinical parameters in lupus nephritis patients","volume":"101","author":"Wangriatisak","year":"2025","journal-title":"Scand J Immunol"},{"key":"2026030916370699000_keag097-B12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.semarthrit.2013.11.010","article-title":"A regulatory role for CD72 expression on B cells in systemic lupus erythematosus","volume":"43","author":"Vadasz","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2026030916370699000_keag097-B13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08916930601118890","article-title":"Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis","volume":"40","author":"Nakano","year":"2007","journal-title":"Autoimmunity"},{"key":"2026030916370699000_keag097-B14","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.23498","article-title":"Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95","volume":"58","author":"Jacobi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026030916370699000_keag097-B15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021342118","article-title":"CD20 as a gatekeeper of the resting state of human B cells","volume":"118","author":"Kl\u00e4sener","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026030916370699000_keag097-B16","doi-asserted-by":"crossref","first-page":"826152","DOI":"10.3389\/fimmu.2022.826152","article-title":"Rituximab in systemic lupus erythematosus: transient effects on autoimmunity associated lymphocyte phenotypes and implications for immunogenicity","volume":"13","author":"Faustini","year":"2022","journal-title":"Front Immunol"},{"key":"2026030916370699000_keag097-B17","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1002\/art.38854","article-title":"Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus","volume":"66","author":"Fleischer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026030916370699000_keag097-B18","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.4049\/jimmunol.1200940","article-title":"Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells","volume":"189","author":"Lee","year":"2012","journal-title":"J Immunol"},{"key":"2026030916370699000_keag097-B19","doi-asserted-by":"crossref","first-page":"1155421","DOI":"10.3389\/fimmu.2023.1155421","article-title":"B cell activation via immunometabolism in systemic lupus erythematosus","volume":"14","author":"Iwata","year":"2023","journal-title":"Front Immunol"},{"key":"2026030916370699000_keag097-B20","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/art.42157","article-title":"Plasmablast-like phenotype among antigen-experienced CXCR5-CD19(low) B cells in systemic lupus erythematosus","volume":"74","author":"Szelinski","year":"2022","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag097\/67106725\/keag097.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/3\/keag097\/67106725\/keag097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/3\/keag097\/67106725\/keag097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:37:18Z","timestamp":1773088638000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag097\/8497164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag097","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,18]]},"article-number":"keag097"}}